BELEODAQ

Serial Number 86140026
Registration 4626277
800

Registration Progress

Application Filed
Dec 10, 2013
Under Examination
Jul 15, 2014
Approved for Publication
May 20, 2014
Published for Opposition
May 20, 2014
Registered
Oct 21, 2014

Trademark Image

BELEODAQ

Basic Information

Serial Number
86140026
Registration Number
4626277
Filing Date
December 10, 2013
Registration Date
October 21, 2014
Published for Opposition
May 20, 2014
Renewal Date
October 21, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Jan 13, 2025
Registration
Registered
Classes
005

Rights Holder

ACROTECH BIOPHARMA INC.

03
Address
279 PRINCETON HIGHTSTOWN ROAD
EAST WINDSOR, NJ 08520

Ownership History

SPECTRUM PHARMACEUTICALS, INC.

Original Applicant
03
IRVINE, CA

SPECTRUM PHARMACEUTICALS, INC.

Owner at Publication
03
IRVINE, CA

SPECTRUM PHARMACEUTICALS, INC.

Original Registrant
03
IRVINE, CA

ACROTECH BIOPHARMA LLC

New Owner After Registration #1
16
EAST WINDSOR, NJ

ACROTECH BIOPHARMA INC.

New Owner After Registration #2
03
EAST WINDSOR, NJ

Legal Representation

Attorney
Lynn E. Rzonca

USPTO Deadlines

Next Deadline
3390 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2014-10-21)
Due Date
October 21, 2034
Grace Period Ends
April 21, 2035

Application History

44 events
Date Code Type Description
Jan 13, 2025 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jan 13, 2025 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 13, 2025 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jan 13, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 24, 2024 E89R I TEAS SECTION 8 & 9 RECEIVED
Sep 5, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 5, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 5, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 5, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 5, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 21, 2023 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 14, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 29, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 29, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 29, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 29, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 29, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 27, 2020 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 27, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 27, 2020 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 2, 2020 E815 I TEAS SECTION 8 & 15 RECEIVED
Oct 21, 2019 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 5, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 21, 2014 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 13, 2014 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 12, 2014 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 10, 2014 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Aug 28, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 11, 2014 EISU I TEAS STATEMENT OF USE RECEIVED
Aug 11, 2014 IUAF S USE AMENDMENT FILED
Jul 15, 2014 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 20, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2014 PUBO A PUBLISHED FOR OPPOSITION
Apr 30, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2014 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 14, 2014 ALIE A ASSIGNED TO LIE
Mar 20, 2014 CNEA R EXAMINERS AMENDMENT -WRITTEN
Mar 20, 2014 GNEA F EXAMINERS AMENDMENT E-MAILED
Mar 20, 2014 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2014 XAEC I EXAMINER'S AMENDMENT ENTERED
Mar 20, 2014 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 19, 2014 DOCK D ASSIGNED TO EXAMINER
Dec 24, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2013 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, those for the treatment, prevention, and diagnosis of bacterial infections, fungal infections and inflammatory, nephrological, neurological, oncological, and urological conditions and diseases
First Use Anywhere: Jul 20, 2014
First Use in Commerce: Jul 20, 2014

Classification

International Classes
005